Search Results 2451-2460 of 20234 for Receptor

  1. Innovative therapies shape the future of chronic lymphocytic leukemia treatment - Mayo Clinic

    BTK inhibitors work by blocking the B-cell receptor signaling pathway. Then in 2016, the FDA approved the first B-cell lymphoma 2 (BCL-2) inhibitor drug for ...

  2. A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria - Mayo Clinic

    other day) doxepin (oral); (iv) leukotriene receptor antagonists (LTRA) (e.g., montelukast, zafirlukast). 7. H1-AH use at greater than approved doses or ...

  3. Neurology - Doctors - Mayo Clinic

    coprotein antibody-associated disease, NMDA receptor antibody encephalitis, Autoimmune encephalitis, Autosomal dominant leukodystrophy. Show more areas of ...

  4. Clinical trials - Oncology (Medical)

    The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

  5. Movement disorders - Doctors and departments - Mayo Clinic

    ... receptor antibody encephalitis. Show more areas of focus for Andrew McKeon, M.B., B.Ch., M.D.. Kai J. Miller, M.D., Ph.D ...

  6. Evaluate The Safety, Tolerability, Pharmacokinetics And Efficacy Of BL-M05D1 In Subjects With Solid Tumors - Mayo Clinic

    2, human epidermal growth factor receptor 2 (HER2), PD-L1 and/or microsatellite instability high (MSI-H)/ mismatch repair deficiency (dMMR) positive tumors ...

  7. Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors - Mayo Clinic

    ... receptor positive (ER+/PR+, and Her2-) metastatic breast cancer, recurrent GBM, GASTRIC/GASTROESOPHAGEAL JUNCTION CANCER, advanced pancreatic adenocarcinoma ...

  8. Mayo Clinic School of Health Sciences 2026 Radiography Program – Jacksonville, Florida

    37 Holding Patients or Image Receptors ... This course presents Digital Radiography, including the design and function of digital image receptors, histogram ...

  9. Neurology - Clinical trials

    Memantine hydrochloride may enhance cognitive function by binding to and inhibiting channels of receptors located in the central nervous system. Radiation ...

  10. Rolapitant (intravenous route) - Mayo Clinic

    This medicine is a substance P/neurokinin 1 (NK1) receptor antagonist that works by blocking the signals to the brain that cause nausea and vomiting. This ...